Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antidepressant
gptkb:norepinephrine_reuptake_inhibitor gptkb:drug |
| gptkbp:approvedBy |
gptkb:FDA
2013 |
| gptkbp:ATCCode |
N06AX28
|
| gptkbp:brand |
Fetzima
|
| gptkbp:CASNumber |
96847-46-8
|
| gptkbp:chemicalFormula |
C15H22N2O
|
| gptkbp:developedBy |
Pierre Fabre Medicament
|
| gptkbp:eliminationHalfLife |
12 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:hasEnantiomer |
gptkb:milnacipran
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
serotonin-norepinephrine reuptake inhibition
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
246.35 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:relatedTo |
gptkb:milnacipran
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation increased heart rate erectile dysfunction hyperhidrosis |
| gptkbp:usedFor |
gptkb:major_depressive_disorder
|
| gptkbp:bfsParent |
gptkb:Serotonin-norepinephrine_reuptake_inhibitors
gptkb:Venlafaxine |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
levomilnacipran
|